These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32033849)

  • 41. The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark.
    Slotved HC; Dalby T; Hoffmann S
    Vaccine; 2016 Feb; 34(6):769-74. PubMed ID: 26772630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of vaccination delay on deaths averted by pneumococcal conjugate vaccine: Modeled effects in 8 country scenarios.
    Carter ED; Tam Y; Walker N
    Vaccine; 2019 Aug; 37(36):5242-5249. PubMed ID: 31375441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative effectiveness of individual pneumococcal vaccines with dual pneumococcal vaccination in older United States Veterans.
    Narsingam S; Munson J; Drescher F
    Vaccine; 2022 Aug; 40(35):5223-5228. PubMed ID: 35927134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine.
    Payeras A; Villoslada A; Garau M; Salvador MN; Gallegos MC
    Int J Infect Dis; 2015 Apr; 33():22-7. PubMed ID: 25541296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children.
    Ruiz-Contreras J; Picazo J; Casado-Flores J; Baquero-Artigao F; Hernández-Sampelayo T; Otheo E; Méndez C; Del Amo M; Balseiro C;
    Vaccine; 2017 Aug; 35(35 Pt B):4646-4651. PubMed ID: 28711388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Change in Pneumococcus Serotypes but not Mortality or Morbidity in Pre- and Post-13-Valent Polysaccharide Conjugate Vaccine Era: Epidemiology in a Pediatric Intensive Care Unit over 10 Years.
    Hon KL; Chan KH; Ko PL; Cheung MHY; Tsang KYC; Chan LCN; Chan RWY; Leung TF; Ip M
    J Trop Pediatr; 2018 Oct; 64(5):403-408. PubMed ID: 29126217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study.
    Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang AB
    Lancet Child Adolesc Health; 2020 Jun; 4(6):425-434. PubMed ID: 32450122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada.
    De Wals P; Lefebvre B; Markowski F; Deceuninck G; Defay F; Douville-Fradet M; Landry M
    Vaccine; 2014 Mar; 32(13):1501-6. PubMed ID: 24486346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006.
    Lepoutre A; Varon E; Georges S; Gutmann L; Lévy-Bruhl D
    Euro Surveill; 2008 Aug; 13(35):. PubMed ID: 18761883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
    van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
    Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine.
    Moïsi JC; Makawa MS; Tall H; Agbenoko K; Njanpop-Lafourcade BM; Tamekloe S; Amidou M; Mueller JE; Gessner BD
    PLoS One; 2017; 12(1):e0170412. PubMed ID: 28114427
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina.
    Urueña A; Pippo T; Betelu MS; Virgilio F; Giglio N; Gentile A; Jimenez SG; Jáuregui B; Clark AD; Diosque M; Vizzotti C
    Vaccine; 2011 Jul; 29(31):4963-72. PubMed ID: 21621575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.
    Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL
    Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children.
    von Kries R; Hermann M; Hachmeister A; Siedler A; Schmitt HJ; Al-Lahham A; Reinert RR
    Pediatr Infect Dis J; 2002 Nov; 21(11):1017-23. PubMed ID: 12442022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of PCV7/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD.
    Ben-Shimol S; Greenberg D; Givon-Lavi N; Schlesinger Y; Miron D; Aviner S; Dagan R;
    Vaccine; 2016 Aug; 34(38):4543-4550. PubMed ID: 27475471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric invasive pneumococcal disease in Taiwan following a national catch-up program with the 13-valent pneumococcal conjugate vaccine.
    Wei SH; Chiang CS; Chiu CH; Chou P; Lin TY
    Pediatr Infect Dis J; 2015 Mar; 34(3):e71-7. PubMed ID: 25247584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment.
    How CH; Phua See Chun P; Shafi F; Jakes RW
    BMC Public Health; 2016 Sep; 16(1):923. PubMed ID: 27590503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infant mortality rates and pneumococcal vaccines: a time-series trend analysis in 194 countries, 1950-2020.
    Sanchez CA; Rivera-Lozada O; Lozada-Urbano M; Best P
    BMJ Glob Health; 2023 Aug; 8(8):. PubMed ID: 37550006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.